MorphoSys To Present At the 40th Annual J.P. Morgan Healthcare Conference
Press release content from Accesswire. The AP news staff was not involved in its creation.
Source: apnews.com
Page 18 - Thomas Biegi News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Thomas Biegi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Thomas Biegi Today - Breaking & Trending Today
MorphoSys AG: MorphoSys To Present At the 40th Annual J.P. Morgan Healthcare Conference
PLANEGG / MUNICH, GERMANY / ACCESSWIRE / Janauary 10, 2022 / MorphoSys AG (FSE:MOR; NASDAQ:MOR), announced today that Jean-Paul Kress, M.D., Chief Executive Officer of MorphoSys, will present at the 40
Source: finanznachrichten.de
MorphoSys AG: Corporate Calendar 2022
PLANEGG/MUNICH, GERMANY / ACCESSWIRE / November 29, 2021 / Corporate Calendar 2022Dear Madam/Sir,Please note MorphoSys' financial reporting dates 2022 as follows:Publication of Interim Statement / ReportConference
Source: finanznachrichten.de
MorphoSys AG: MorphoSys Presents Interim Results from M-PLACE Study with Felzartamab during American Society of Nephrology Annual Meeting
Felzartamab has the potential to rapidly and substantially reduce anti-PLA2R antibody titers in patients with anti-PLA2R-positive membranous nephropathyPLANEGG/MUNICH, GERMANY / ACCESSWIRE / November 4
Source: finanznachrichten.de
MorphoSys AG Announces Monjuvi Sales for the First Nine Months and Third Quarter of 2021 and Invitation to the Upcoming Conference Call on November 11, 2021
PLANEGG/MUNICH, GERMANY / ACCESSWIRE / November 2, 2021 / MorphoSys AG (FSE:MOR); (NASDAQ:MOR) today announces that revenues from product sales of Monjuvi (R) (tafasitamab-cxix) in the U.S. amount to €
Source: finanznachrichten.de